Phibro Animal Health Corporation (PAHC) Stock Analysis & Winston Score

Phibro Animal Health Corporation makes medicines and health products for farm animals. Its main products include antibiotics, vaccines, and nutritional supplements used to keep livestock — like chickens, pigs, and cattle — healthy and growing efficiently. The company sells primarily to large commercial farms, feed manufacturers, and veterinarians, making it a key supplier in the agricultural and animal health industry. Phibro earns money by selling these products directly to customers, with no subscription model — revenue comes from product sales across its Animal Health and Mineral Nutrition segments. The company operates globally, with a meaningful presence in the United States, Latin America, and other international markets, generating roughly $1 billion or more in annual revenue. Its long-standing customer relationships and specialized manufacturing give it a degree of competitive stability, but the business faces ongoing risk from regulatory pressure on antibiotic use in livestock, which could reduce demand for some of its core products over time.